-
[Detection of transfusion transmitted virus (TTV) DNA in sera among three dif...
International audience -
Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor ...
International audience -
Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends...
International audience -
Kinases required in hepatitis C virus entry and replication highlighted by sm...
International audience -
Antiviral effect of ribonuclease conjugated oligodeoxynucleotides targeting t...
International audience -
Recent contributions of in vitro models to our understanding of hepatitis C v...
International audience -
Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets fo...
International audience -
[Open Sesame: regulation of hepatitis C virus entry into hepatocytes].
International audience -
Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A an...
International audience -
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targ...
International audience -
Targeted inhibition of the hepatitis C internal ribosomal entry site genomic ...
International audience -
Viral sequence variation in chronic carriers of hepatitis C virus has a low i...
International audience -
Prospects for prophylactic hepatitis C vaccines based on virus-like particles.
International audience -
SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C v...
International audience -
Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA p...
International audience -
Novel HCV replication mouse model using human hepatocellular carcinoma xenogr...
In the absence of an immunocompetent mouse model for HCV replication, we developed a convenient xenograft mouse model that produces infectious viral particles. For... -
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral loa...
International audience -
No increased mortality from donor or recipient hepatitis B- and/or hepatitis ...
International audience -
Pharmacological exposure to ribavirin: a key player in the complex network of...
International audience -
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI2013...
International audience
